Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Biological
  • Participants: 25
  • Start Date: February 11, 2021
Phase 2 Pilot Study to Evaluate Efficacy and Safety of Anakinra to Prevent CD19-Targeted CAR-T Cell-Related Cytokine Release Syndrome (CRS) and Neurotoxicity in Patients With B Cell Lymphoma
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 20
  • Start Date: October 5, 2020
A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 142
  • Start Date: July 6, 2020
Phenobarbital Versus Ativan for Refractory Alcohol Withdrawal Treatment in the Intensive Care Unit
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Drug
  • Participants: 1000
  • Start Date: February 19, 2020
Thiamine Administration and Prevalence of Delirium in the Intensive Care Unit: A Before-after Study
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 62
  • Start Date: February 7, 2020
A Phase 2, Single-Arm, Open-Label Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Dietary Supplement
  • Participants: 80
  • Start Date: February 3, 2020
The Effect of Hericium Erinaceus Mycelium in Non-motor Symptoms of Parkinson's Disease
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Drug
  • Participants: 120
  • Start Date: November 11, 2019
Anesthetic Neurotoxicity: the Association Between General Anesthesia and the Level of Plasma Neurofilament Light
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Drug
  • Participants: 120
  • Start Date: June 1, 2019
Preventing Levodopa Induced Dyskinesia in Parkinson?s Disease With Statins
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: April 1, 2018
A Pilot Study to Evaluate Impact on Neurological Side Effects (Cognition, Memory, and Tremor) in Elderly (Age>65) Patients
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 450
  • Start Date: August 10, 2017
Neurodevelopmental Outcome After Standard Dose Sevoflurane Versus Low-dose Sevoflurane/Dexmedetomidine/Remifentanil Anaesthesia in Young Children- The TREX Trial
Showing 1-11 of 11